Found: 20
Select item for more details and to access through your institution.
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vemurafenib and Radiosensitization.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 7, p. 855, doi. 10.1001/jamadermatol.2013.4200
- By:
- Publication type:
- Article
Contribution of collegial support meetings (CSM) in the management of complex situations of patients with advanced cancer.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 6, p. 1, doi. 10.1007/s00520-023-07782-8
- By:
- Publication type:
- Article
Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?
- Published in:
- Seminars in Immunopathology, 2017, v. 39, n. 3, p. 327, doi. 10.1007/s00281-016-0613-x
- By:
- Publication type:
- Article
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053745
- By:
- Publication type:
- Article
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1571, doi. 10.1007/s00262-018-2219-8
- By:
- Publication type:
- Article
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13360-6
- By:
- Publication type:
- Article
Kidney injuries related to ipilimumab.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 769, doi. 10.1007/s10637-014-0092-7
- By:
- Publication type:
- Article
Severe meningo-radiculo-nevritis associated with ipilimumab.
- Published in:
- 2012
- By:
- Publication type:
- Report
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
- Published in:
- Cell Research, 2015, v. 25, n. 3, p. 399, doi. 10.1038/cr.2015.28
- By:
- Publication type:
- Article
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
- Published in:
- Cell Research, 2015, v. 25, n. 2, p. 208, doi. 10.1038/cr.2015.3
- By:
- Publication type:
- Article
Defining the clinical condition of cancer patients: it is time to switch from performance status to nutritional status.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Renal toxicities associated with pembrolizumab.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 81, doi. 10.1093/ckj/sfy100
- By:
- Publication type:
- Article
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 3, p. 235, doi. 10.1007/s40261-015-0373-8
- By:
- Publication type:
- Article
Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma.
- Published in:
- Acta Dermato-Venereologica, 2017, v. 97, n. 3, p. 408, doi. 10.2340/00015555-2504
- By:
- Publication type:
- Article
Blue Lymphangitis of the Breast after Breast Cancer: Case Report.
- Published in:
- Breast Journal, 2017, v. 23, n. 3, p. 348, doi. 10.1111/tbj.12738
- By:
- Publication type:
- Article
Correlation of Phenotype/Genotype in a Cohort of 23 Xeroderma Pigmentosum-Variant Patients Reveals 12 New Disease-Causing POLH Mutations.
- Published in:
- Human Mutation, 2014, v. 35, n. 1, p. 117, doi. 10.1002/humu.22462
- By:
- Publication type:
- Article
Renal effects of immune checkpoint inhibitors.
- Published in:
- Nephrology Dialysis Transplantation, 2017, v. 32, n. 6, p. 936, doi. 10.1093/ndt/gfw382
- By:
- Publication type:
- Article
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 10, p. 1238, doi. 10.1093/ecco-jcc/jjx081
- By:
- Publication type:
- Article
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16079-x
- By:
- Publication type:
- Article